Mahendra Sanapati, MD
Interventional Pain Medicine · Evansville, INNPI 1154325959
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2019 at $12,945 and has fallen 86.3% since, to $1,773 in 2025. Among interventional pain medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $63.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$7K
- Medtronic$7K
- Nevro Corp.$4K
- Spinal Simplicity, LLC$2K
- Si-bone, Inc.$2K
- Boston Scientific$1K
- plus $8K from 27 others
Across 70 payments — averaging $2794.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$183K
- MDD US Operations, LLC$6K
- Nevro Corp.$4K
- Stimwave Technologies Incorporated$2K
- Flowonix Medical Incorporated$1K
What the payments were for
- Consulting fees$4,93016%
- Travel & lodging$8,63628%
- Food & beverage$16,12152%
- Education$960%
- Entertainment$9663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 10 | $7,145 |
| Medtronic(3 entities) | 181 | $6,585 |
| Nevro Corp. | 92 | $4,333 |
| Spinal Simplicity, LLC | 21 | $1,876 |
| Si-bone, Inc. | 14 | $1,653 |
| Boston Scientific | 50 | $1,485 |
| Surgentec | 1 | $1,376 |
| Flowonix Medical Incorporated | 2 | $1,181 |
| Globus Medical | 35 | $1,165 |
| Stimwave Technologies Incorporated | 19 | $701 |
| Abbott | 11 | $674 |
| Vertos Medical, Inc. | 6 | $451 |
| MML US, Inc. | 8 | $381 |
| Curonix LLC | 3 | $281 |
| Neuronetics, Inc. | 2 | $216 |
| AbbVie(2 entities) | 8 | $194 |
| Amgen | 2 | $180 |
| Relievant Medsystems, Inc. | 2 | $167 |
| E.r. Squibb & Sons, L.L.C. | 1 | $128 |
| Eisai Inc. | 1 | $81 |
| Axonics, Inc. | 2 | $67 |
| Saluda Medical Americas, Inc. | 1 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $55 |
| Bayer | 1 | $53 |
| Biotronik NRO, Inc. | 1 | $49 |
| Bioventus LLC | 1 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Stryker | 1 | $34 |
| Vertex | 1 | $27 |
| Zimmer Biomet | 1 | $26 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lucemyra/Lofexidine$6,809
- Senza Spinal Cord Stimulation System$1,849
- HA MINUTEMAN G3-R$1,578
- ION Facet Screw System$1,376
- Prometra II$1,181
- ClosureFast$1,008
- SYNCHROMED$833
- IFUSE IMPLANT SYSTEM$803
- Omnia$522
- INTELLIS$439
- mild Device Kit$365
- CORRIDOR$360
- Senza$341
- Intracept$260
- INTELLIS ADAPTIVESTIM$230
- ETERNA$194
- GENERAL PAIN MANAGEMENT$162
- PROCLAIM$162
- NEUROSTAR TMS THERAPY$158
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$142
How this compares
$30,749 in reported general payments places this provider in the 95th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 59 | $86,382 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,017 | $46,784 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,319 | $28,670 |
| Lidocaine | 129 | $22,904 |
| Gabapentin | 543 | $6,045 |
| Buprenorphine | 24 | $5,451 |
| Oxycodone Hcl | 301 | $4,997 |
| Hydromorphone Hcl | 278 | $4,352 |
| Pregabalin | 154 | $3,298 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $2,994 |
| Morphine Sulfate ErMorphine Sulfate | 87 | $2,143 |
| Fentanyl | 18 | $1,646 |
| Methadone Hcl | 97 | $1,626 |
| Morphine Sulfate | 62 | $1,442 |
| Tizanidine Hcl | 148 | $1,019 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Evansville
- Mansoor KhanEvansville$5K
- Randall OliverEvansville$4K
- Amy WalkerEvansville$1K
- Yusuf RashadaEvansville$339
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.